Skip to main content
. 2022 Oct 13;14(10):2183. doi: 10.3390/pharmaceutics14102183

Figure 4.

Figure 4

(A) Cumulative drug release from Lip-DOX, Lip-CB, Lip-DOX/CB, PEG-Lip-DOX, PEG-Lip-CB, and PEG-Lip-DOX/CB and (B) cell viability effects of Lip-DOX, Lip-CB, Lip-DOX/CB, PEG-Lip-DOX, PEG-Lip-CB, and PEG-Lip-DOX/CB three months after preparation. The data are expressed as mean ± SD (n = 3).